877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Kappa agonists, Opioid receptor ligands, Drugs acting on the nervous system, Convulsants

Categories

Analgesics (2)
Cyclic compounds (2)
Neurotoxins (2)
Opioids (2)
Psychoactive drugs (2)
Analgesic (1)
Anesthetics (1)
Antiarrhythmic agents (1)
Cycloalkanes (1)
Cyclobutanes (1)
Delta-opioid agonists (1)
Dissociative drugs (1)
Drugs acting on the cardiovascular system (1)
Euphoriants (1)
Four-membered rings (1)
Local anesthetics (1)
Monoamine reuptake inhibitors (1)
Mu-opioid agonists (1)
Pharmaceuticals (1)
Piperidines (1)
Semisynthetic opioids (1)
Serotonin-norepinephrine-dopamine reuptake inhibitors (1)
Six-membered rings (1)
Sodium channel blockers (1)
Synthetic opioids (1)

Suppliers

Sigma Aldrich (1)

meperidine (57-42-1)  
Demerol  ·  Dolin  ·  Pethidine
Pethidine, also known as meperidine and sold under the brand name Demerol among others, is a synthetic opioid pain medication of the phenylpiperidine class. Synthesized in 1939 as a potential anticholinergic agent by the German chemist Otto Eisleb, its analgesic properties were first recognized by Otto Schaumann while working for IG Farben, Germany. Pethidine is the prototype of a large family of analgesics including the pethidine 4-phenylpiperidines (piminodine, anileridine and others), the prodines (alphaprodine, MPPP, etc.), bemidones (ketobemidone, etc.) and others more distant, including diphenoxylate and analogues.
Xorphanol (77287-89-9)  
Xorphanol (INN) (developmental code name TR-5379 or TR-5379M), also known as xorphanol mesylate (USAN), is an opioid analgesic of the morphinan family that was never marketed. Xorphanol is a mixed agonist–antagonist of opioid receptors, acting preferentially as a high-efficacy partial agonist/near-full agonist of the κ-opioid receptor (Ki = 0.4 nM; EC50 = 3.3 nM; Imax = 49%; IA = 0.84) and to a lesser extent as a partial agonist of the μ-opioid receptor (Ki = 0.25 nM; IC50 = 3.4 nM; Imax = 29%) with lower relative intrinsic activity and marked antagonistic potential (including the ability to antagonize morphine-induced effects and induce opioid withdrawal in opioid-dependent individuals). The drug has also been found to act as an agonist of the δ-opioid receptor (Ki = 1.0 nM; IC50 = 8 nM; Imax = 76%).
Related searches
Kappa agonists
Opioid receptor ligands
Drugs acting on the nervous system
Convulsants